Heme arginate

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Heme arginate
Identifiers
100438-92-4 YesY
MeSH Heme+arginate
PubChem 3086464
UNII R1B526117P YesY
Properties
C40H48FeN8O6+2
Molar mass 792.704
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
YesY verify (what is YesYN ?)
Infobox references

Heme arginate (or haem arginate) is a compound of heme and arginine used in the treatment of acute porphyrias.[1][2] This heme product is only available outside the United States and is equivalent to hematin.[3]

Heme arginate is a heme compound, whereby L-arginine is added to prevent rapid degradation. It is given intravenously, and its action of mechanism is to reduce the overproduction of δ-aminolevulinic acid, which can cause the acute symptoms in an attack of the acute porphyrias.[4]

See also[edit]

References[edit]

  1. ^ "HAEM ARGINATE FOR THE ACUTE ATTACK OF PORPHYRIA". Porphyria South Africa. 
  2. ^ "Treatment of the Acute Attack". European Porphyria Network. Retrieved 28 August 2011. 
  3. ^ "Panhematin for Acute Porphyria". American Porphyria Foundation. Retrieved 8 July 2016. 
  4. ^ Volin, L; V Rasi; E Vahtera; R Tenhunen (1988). "Heme arginate: effects on hemostasis" (PDF). Blood Journal. 71: 625–628. Retrieved 28 August 2011.